Comments
Loading...
Milestone Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:MIST | Benzinga
Milestone Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.170
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Milestone Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -$0.21 | -$0.17 | — | — | $0.00 | — | — | — | 05/12/2025 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.32 | -$0.15 | -$0.19 | -26.67% | $0.00 | — | $0.00 | — | 03/13/2025 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.35 | -$0.16 | -$0.14 | 12.50% | $0.00 | — | $0.00 | — | 11/12/2024 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.37 | -$0.19 | -$0.14 | 26.32% | $0.00 | — | $0.00 | — | 08/08/2024 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.35 | -$0.26 | -$0.21 | 19.23% | $1.00M | — | $0.00 | — | 05/13/2024 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.31 | -$0.31 | -$0.32 | -3.23% | $3.50M | — | $0.00 | — | 03/21/2024 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.34 | -$0.38 | -$0.35 | 7.89% | $1.50M | — | $0.00 | — | 11/13/2023 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.39 | -$0.39 | -$0.37 | 5.13% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.33 | -$0.40 | -$0.35 | 12.50% | $0.00 | — | $1.00M | — | 05/11/2023 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.40 | -$0.33 | -$0.31 | 6.06% | $0.00 | $870.00K | $3.50M | 302.30% | 03/29/2023 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.34 | -$0.41 | -$0.34 | 17.07% | $0.00 | — | $1.50M | — | 11/10/2022 | Get Alert |
| MIST | Milestone Pharmaceuticals | $0.02 | -$0.36 | -$0.39 | -8.33% | $15.00M | — | $0.00 | — | 08/10/2022 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.30 | -$0.39 | -$0.33 | 15.38% | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.23 | -$0.36 | -$0.40 | -11.11% | $0.00 | — | $0.00 | — | 03/24/2022 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.40 | -$0.38 | -$0.34 | 10.53% | $0.00 | — | $0.00 | — | 11/12/2021 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.53 | -$0.26 | $0.02 | 107.69% | $0.00 | $3.00M | $15.00M | 400.00% | 08/11/2021 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.67 | — | -$0.30 | — | $0.00 | — | $0.00 | — | 05/17/2021 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.75 | — | -$0.23 | — | $0.00 | — | $0.00 | — | 03/29/2021 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$0.52 | — | -$0.40 | — | $0.00 | — | $0.00 | — | 11/13/2020 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$1.04 | — | -$0.53 | — | $0.00 | — | $0.00 | — | 08/12/2020 | Get Alert |
| MIST | Milestone Pharmaceuticals | -$17.32 | — | -$0.67 | — | — | — | $0.00 | — | 05/14/2020 | Get Alert |
Milestone Pharmaceuticals (MIST) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.19 | $-0.15 | -26.7 % |
| Q3 | 2024-11-12 | $-0.14 | $-0.16 | 12.5 % |
| Q2 | 2024-08-08 | $-0.14 | $-0.19 | 26.3 % |
| Q1 | 2024-05-13 | $-0.21 | $-0.26 | 19.2 % |
Milestone Pharmaceuticals (MIST) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2023-03-29 | $3.50M | $870.00K | 302.3 % |
| Q2 | 2021-08-11 | $15.00M | $3.00M | 400.0 % |
FAQ
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals (MIST) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Milestone Pharmaceuticals (NASDAQ:MIST)?
The Actual EPS was $-0.19, which missed the estimate of $-0.15.
What were Milestone Pharmaceuticals’s (NASDAQ:MIST) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
